KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Assets Average (2016 - 2025)

Historic Assets Average for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $80.9 billion.

  • Gsk's Assets Average rose 880.0% to $80.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 billion, marking a year-over-year increase of 880.0%. This contributed to the annual value of $74.7 billion for FY2024, which is 106.4% up from last year.
  • According to the latest figures from Q3 2025, Gsk's Assets Average is $80.9 billion, which was up 880.0% from $77.8 billion recorded in Q2 2025.
  • Over the past 5 years, Gsk's Assets Average peaked at $108.1 billion during Q3 2021, and registered a low of $70.8 billion during Q4 2022.
  • In the last 5 years, Gsk's Assets Average had a median value of $76.4 billion in 2025 and averaged $83.7 billion.
  • Per our database at Business Quant, Gsk's Assets Average plummeted by 3416.02% in 2022 and then skyrocketed by 880.0% in 2025.
  • Over the past 5 years, Gsk's Assets Average (Quarter) stood at $107.6 billion in 2021, then plummeted by 34.16% to $70.8 billion in 2022, then increased by 6.14% to $75.2 billion in 2023, then increased by 0.94% to $75.9 billion in 2024, then rose by 6.63% to $80.9 billion in 2025.
  • Its last three reported values are $80.9 billion in Q3 2025, $77.8 billion for Q2 2025, and $76.4 billion during Q1 2025.